Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

TURNING POINT BRANDS, INC.

(TPB)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Turning Point Brands : FDA Issues Marketing Denial Order For Vapor Products Application

09/17/2021 | 06:21am EDT

By Michael Dabaie

Turning Point Brands Inc. said the U.S. Food and Drug Administration denied the company's application to market some of its vapor products.

Turning Point said it will continue to engage with the FDA and other stakeholders as it considers options, including a formal appeal of the decision and potential legal relief.

"While we believe the FDA's current conclusion is misguided, we will continue our dialogue with the agency in search of a path forward," said Chief Executive Larry Wexler.

Turning Point's premarket tobacco product application included an in-depth toxicological review, a clinical study, and studies on patterns and likelihood of use, the company said.

Write to Michael Dabaie at michael.dabaie@wsj.com

(END) Dow Jones Newswires

09-17-21 0821ET

All news about TURNING POINT BRANDS, INC.
10/12TURNING POINT BRANDS : to Host Third Quarter 2021 Conference Call
BU
10/12TURNING POINT BRANDS : FDA Rescinds Previously Disclosed Marketing Denial Order for Turnin..
PU
10/12TURNING POINT BRANDS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
10/12U.S. Food and Drug Administration Rescinds Previously Disclosed Marketing Denial Order ..
CI
10/11Consumer Stocks Decline Pre-Bell Monday
MT
10/11TURNING POINT BRANDS : Consumer
MT
10/11TURNING POINT BRANDS : FDA Rescinds Marketing Denial Order for Turning Point Brands' Vapor..
MT
10/11TURNING POINT BRANDS : FDA Rescinds Previously Disclosed Marketing Denial Order for Turnin..
BU
10/11Turning Point Brands, Inc. Announces FDA Rescinds Previously Disclosed Marketing Denial..
CI
10/11Turning Point Says FDA Rescinds Marketing Denial Order for Vapor Products
DJ
More news
Analyst Recommendations on TURNING POINT BRANDS, INC.
More recommendations
Financials (USD)
Sales 2021 457 M - -
Net income 2021 54,2 M - -
Net Debt 2021 223 M - -
P/E ratio 2021 19,4x
Yield 2021 0,45%
Capitalization 881 M 881 M -
EV / Sales 2021 2,42x
EV / Sales 2022 2,19x
Nbr of Employees 408
Free-Float 92,3%
Chart TURNING POINT BRANDS, INC.
Duration : Period :
Turning Point Brands, Inc. Technical Analysis Chart | TPB | US90041L1052 | MarketScreener
Technical analysis trends TURNING POINT BRANDS, INC.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 46,56 $
Average target price 65,40 $
Spread / Average Target 40,5%
EPS Revisions
Managers and Directors
Lawrence S. Wexler President, Chief Executive Officer & Director
Louie Reformina Chief Financial Officer
David E. Glazek Chairman
Christian Allen Senior Vice President-Information Technology
Sarah Evans Director-Scientific & Regulatory Affairs